Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michele Ghidini

Showing results (1-10 of 206) with videos related to

Pageof 21
Sort By:
Frontiers in Medicine|July 2, 2015
Non-Coding RNAs in Primary Liver CancerMichele Ghidini, Chiara Braconi
Current Treatment Options in Oncology|May 26, 2018
Right Versus Left Colon Cancer: Resectable and Metastatic DiseaseMichele Ghidini, Fausto Petrelli, Gianluca Tomasello
World Journal of Gastroenterology|March 22, 2024
Colon and rectal cancer: An emergent public health problemMarina Pinheiro, David Nascimento Moreira, Michele Ghidini
JAMA Oncology|May 15, 2020
Outcomes Following Immune Checkpoint Inhibitor Treatment of Patients With Microsatellite Instability-High Cancers: A Systematic Review and Meta-analysisFausto Petrelli, Michele Ghidini, Antonio Ghidini, et al.
Current Drug Targets|November 6, 2020
Circulating Tumor DNA as a Biomarker for Outcomes Prediction in Colorectal Cancer PatientsAngelica Petrillo, Massimiliano Salati, Dario Trapani, et al.
Genes|July 2, 2021
Special Issue: Molecular Biomarkers in Solid TumorsNicola Fusco, Caterina Marchiò, Michele Ghidini, et al.
Biology|March 6, 2021
The Role and Expression of Angiogenesis-Related miRNAs in Gastric CancerMartina Giuppi, Anna La Salvia, Jessica Evangelista, et al.
European Journal of Cancer (Oxford, England : 1990)|June 14, 2020
Developing a risk assessment score for patients with cancer during the coronavirus disease 2019 pandemicAlice Indini, Erika Rijavec, Michele Ghidini, et al.
Anti-Cancer Drugs|October 18, 2016
Modified schedules of DCF chemotherapy for advanced gastric cancer: a systematic review of efficacy and toxicityFausto Petrelli, Gianluca Tomasello, Michele Ghidini, et al.
Pharmaceutics|June 2, 2021
Targeting KRAS in Solid Tumors: Current Challenges and Future Opportunities of Novel KRAS InhibitorsAlice Indini, Erika Rijavec, Michele Ghidini, et al.
Pageof 21

Showing results (1-10 of 206) with videos related to

Sort By:
Pageof 21
Frontiers in Medicine|July 2, 2015
Non-Coding RNAs in Primary Liver CancerMichele Ghidini, Chiara Braconi
Current Treatment Options in Oncology|May 26, 2018
Right Versus Left Colon Cancer: Resectable and Metastatic DiseaseMichele Ghidini, Fausto Petrelli, Gianluca Tomasello
World Journal of Gastroenterology|March 22, 2024
Colon and rectal cancer: An emergent public health problemMarina Pinheiro, David Nascimento Moreira, Michele Ghidini
JAMA Oncology|May 15, 2020
Outcomes Following Immune Checkpoint Inhibitor Treatment of Patients With Microsatellite Instability-High Cancers: A Systematic Review and Meta-analysisFausto Petrelli, Michele Ghidini, Antonio Ghidini, et al.
Current Drug Targets|November 6, 2020
Circulating Tumor DNA as a Biomarker for Outcomes Prediction in Colorectal Cancer PatientsAngelica Petrillo, Massimiliano Salati, Dario Trapani, et al.
Genes|July 2, 2021
Special Issue: Molecular Biomarkers in Solid TumorsNicola Fusco, Caterina Marchiò, Michele Ghidini, et al.
Biology|March 6, 2021
The Role and Expression of Angiogenesis-Related miRNAs in Gastric CancerMartina Giuppi, Anna La Salvia, Jessica Evangelista, et al.
European Journal of Cancer (Oxford, England : 1990)|June 14, 2020
Developing a risk assessment score for patients with cancer during the coronavirus disease 2019 pandemicAlice Indini, Erika Rijavec, Michele Ghidini, et al.
Anti-Cancer Drugs|October 18, 2016
Modified schedules of DCF chemotherapy for advanced gastric cancer: a systematic review of efficacy and toxicityFausto Petrelli, Gianluca Tomasello, Michele Ghidini, et al.
Pharmaceutics|June 2, 2021
Targeting KRAS in Solid Tumors: Current Challenges and Future Opportunities of Novel KRAS InhibitorsAlice Indini, Erika Rijavec, Michele Ghidini, et al.
Pageof 21